Even before the shooting in Parkland, Florida, funders were backing local approaches to curbing gun violence. Now, some—like Cal Wellness—are looking to fuel the new student activism on guns and other issues.
In an era of mega-givers and "big bets," making lots of very small grants may seem out of step with the times. But as we’ve reported, quite a few funders give out mini-grants for different reasons. Here’s an example.
A group of heavy hitters, now including the Gates Foundation, are backing a research effort to ensure that global health systems aren’t outflanked by antibiotic-resistant bacteria. The stakes could hardly be higher.
With arts donors increasingly drawn to programs that advance social goals, we dig into a new initiative exploring how visual art, film, and dance can address mental health issues facing New Yorkers.
It’s a public health scourge that’s ravaging marginalized groups while elected officials dither. That sounds awfully familiar, which is why HIV/AIDS funders have a lot to share when it comes to the opioid crisis.
Even as foundations step up their work on homelessness and affordable housing, some new heavy-hitters are coming to this issue, including health insurers. The rise of impact investing is also creating exciting new possibilities.
The growth of health legacy foundations has been one of the biggest stories in philanthropy in recent years. A case in point: the sudden appearance of a new $3.2 billion grantmaker in New York.
Despite a fast-aging population and growing strains on healthcare entitlements, only a limited number of funders are looking at ways our society can better manage how people die. Still, some money is flowing.
The Aileen Getty Foundation has joined two high-profile grantmakers making waves on the HIV/AIDS funding scene in the Southern states. Who’s winning grants from this new collaboration?
It troubling to think that pharma firms may reap PR benefits with philanthropy to address a problem they helped create. On the other hand, any and all new funding is badly needed to fund anti-opioid efforts.
When a profit-thirsty global corporation causes a devastating public health crisis, what should we think when it steps forward with a modest philanthropic pledge to address that crisis?
The play movement recently scored a big investment from a relatively new billion-dollar foundation. This isn't the only deep-pocketed funder that backing a drive to expand play opportunities for low-income kids.
Amid a growing opioid epidemic, one of the many places were addiction during pregnancy is a growing problem is the state of Montana. A health legacy foundation is trying to tackle the problem.
While few national funders are taking on the opioid epidemic, some regional grantmakers are finally starting to take action. A case in point is the Colorado Health Foundation.
Backed by a deep-pocketed foundation, the Society of Family Planning is launching new work to make the abortion pill more accessible at a time when abortion clinics are becoming scarcer in many places.
Robert and Karen Hale awarded $50 million gifts to both the Boston Children’s Hospital and Brigham and Women’s Hospital to support patient care innovations at the hospitals.
Top health grantmakers have been so busy working upstream on the causes of poor health that they've been MIA on the worst public health crisis in recent memory. But here's a funder that's paying new attention.
With a strict focus on New England, the Harvard Pilgrim Health Company is a not-for-profit health services company with philanthropic interests. We look at the insurer's recent grantmaking in Boston and beyond.
The NORCAL Group Foundation was launched in September 2017 and just gave out its first round of grants. The funder is focused on patient care, patient safety, and physician wellness.
Texas has one of the highest maternal mortality rates in the country. This issue is finally getting attention from government and at least one big private funder in the state.
Health legacy foundations have become big, important players in regional philanthropy. And more of them are tackling the social determinants of health. A case in point: a Texas funder with $1.2 billion in assets.
The philanthropic arm of a pharmaceutical company branches out from its usual focus on diseases to look at the social determinants of health with a new gift and funding stream.
The Colorado Health Foundation's new coalition to end hunger is another example of foundations looking to engage a wider range of stakeholders to move the needle on a persistent social problem.
Private foundations like Robert Wood Johnson have led a push to address the social and economic determinants of health. Now, this approach is catching on with more corporate funders.
Even as new wealth flows for medical research and name-brand hospitals, basic care for low-income communities tends to fall through the cracks. We explore this disparity in the context of a big grant in L.A.
The Tufts Health Plan Foundation is taking a long-term and forward-thinking approach to aging issues in New England. We take a quick look.
The Blue Cross Blue Shield of Massachusetts Foundation gives to community groups in Boston and elsewhere in the state with a big emphasis on access.
Gilead Sciences recently announced a 10-year, $100 million commitment to combat HIV/AIDS in the South—the latest funder to respond to a disturbingly high prevalence of infections in the region.
Food companies have a history of using funding research that minimizes the health risks of their products. They're still doing it—in developing countries where obesity is rising fast.
Amid intense uncertainty around healthcare policy, a California-based funder is backing a new journalistic effort to explore health inequities across underserved communities.